Safety, tolerability and pharmacokinetics of 21 day multiple oral administration of a new oxazolidinone antibiotic, LCB01-0371, in healthy male subjects

Linezolid-associated reticulocytopenia

(2016) Danielle H. Oh et al.   ANNALS OF HEMATOLOGY

Characterization of the haematological profile of 21 days of tedizolid in healthy subjects

(2016) Thomas P. Lodise et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens

(2015) George G. Zhanel et al.   DRUGS

Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis

(2015) Taeksun Song et al.   EBioMedicine

Clinical Population Pharmacokinetics and Toxicodynamics of Linezolid

(2014) Lauren M. Boak et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients

(2014) Kazuaki Matsumoto et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In Vitro,In Vivo, and Clinical Studies of Tedizolid To Assess the Potential for Peripheral or Central Monoamine Oxidase Interactions

(2013) S. Flanagan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients

(2012) F. Pea et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis

(2012) Myungsun Lee et al.   NEW ENGLAND JOURNAL OF MEDICINE

The oxazolidinones: past, present, and future

(2011) Karen Joy Shaw et al.   Annals of the New York Academy of Sciences

Population Pharmacokinetic and Pharmacodynamic Analysis of Linezolid and a Hematologic Side Effect, Thrombocytopenia, in Japanese Patients

(2011) Tomohiro Sasaki et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro and In Vivo Activities of LCB01-0371, a New Oxazolidinone

(2010) J.-W. Jeong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibacterial oxazolidinones: emerging structure–toxicity relationships

(2010) Adam R Renslo   Expert Review of Anti-Infective Therapy

Linezolid for the treatment of drug-resistant infections

(2008) David J Herrmann et al.   Expert Review of Anti-Infective Therapy